exhibited significant activity against both sensitive and resistant strains of M. tuberculosis and also against non-tuberculous mycobacteria. To facilitate drug design of benzoxazole as potential antituberculosis agent, we have explored the quantitative structure–activity relationship (QSAR). We demonstrated that lower lipophilicity has significant contribution to activity. Dinitrobenzylsulfanyl derivative
                                    合成了一组
苯并恶唑的2-苄基
硫烷基衍
生物,并评估了其对结核分枝杆菌,非结核分枝杆菌和耐多药结核分枝杆菌的体外分枝杆菌活性。活性表示为最小抑制浓度(MIC),单位为mmol / L。该物质对所有测试菌株显示出相似的活性。一组二硝基衍
生物中的先导化合物对结核分枝杆菌的敏感菌株和耐药菌株均显示出显着活性还可以抵抗非结核分枝杆菌。为了促进
苯并恶唑作为潜在的抗结核药物的药物设计,我们探索了定量构效关系(Q
SAR)。我们证明,较低的亲脂性对活性有重大贡献。
苯并恶唑的二硝基苄基
硫烷基衍
生物代表了有希望的小分子合成抗分枝杆菌。